細胞内シグナル伝達の世界市場予測(~2022年):内分泌、傍分泌

◆英語タイトル:Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022
◆商品コード:MAM-BT5257
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年5月12日
◆ページ数:215
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、細胞内シグナル伝達の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、細道別分析、製品別分析、技術別分析、細胞内シグナル伝達の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.The cell signaling market is categorized based on type, product, technology, pathway, application, and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types (neuronal and intracrine signaling). The endocrine segment is estimated to account the largest share of the cell signaling market in 2017.

By product, the cell signaling market is categorized into consumables (antibodies, reagents, assay kits and other consumables) and instruments. In 2017, the consumables segment is estimated to account the largest share of the market.
The technology segment of the cell signaling market includes microscopy, western blotting, immunohistochemistry (IHC), flow cytometry, enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share of the cell signaling market in 2017.

On the basis of the pathway, the cell signaling market is categorized into Akt, AMP-activated protein kinase (AMPK), ErbB/HER, Hedgehog (Hh), Janus kinase and signal transducer and activator of transcription (JAK/STAT), NF-κB, Notch, and other signaling pathways. In 2017, the Akt segment is estimated to account the largest share of the cell signaling market.

The application segment of cell signaling market includes research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the cell signaling market in 2017.

Geographically, the cell signaling market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
The major players in the cell signaling market include Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Bio-Techne Corporation (U.S.), and Abcam plc (U.K.)

Research Coverage:
Apart from comprehensive geographic analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles also comprise of product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. This market research data can help key players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell signaling market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthening their shares in the cell signaling market.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios of the top players in the cell signaling market. The report analyzes the cell signaling market, by type, product, technology, pathway, application, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell signaling market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the cell signaling market
• Market Development: Comprehensive information about emerging markets. This report analyses the cell signaling market across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell signaling market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23
2.1 SECONDARY DATA 24
2.1.1 KEY DATA FROM SECONDARY SOURCES 24
2.2 PRIMARY DATA 25
2.2.1 KEY DATA FROM PRIMARY SOURCES 26
2.3 MARKET SIZE ESTIMATION 26
2.3.1 BOTTOM-UP APPROACH 27
2.3.2 TOP-DOWN APPROACH 27
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 29
2.5 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHTS 36
4.1 CELL SIGNALING: MARKET OVERVIEW 36
4.2 GEOGRAPHIC ANALYSIS: CELL SIGNALING MARKET, BY SIGNALING TYPE &
REGION (2017) 37
4.3 CELL SIGNALING MARKET, BY PATHWAY, 2017–2022 38
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL SIGNALING MARKET 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising incidence of chronic diseases 41
5.2.1.2 Availability of funding for cell-based research 42
5.2.1.3 Technological advancements in cell-based research instruments 43
5.2.1.4 Growth of end-use industries 43

5.2.2 RESTRAINTS 44
5.2.2.1 High cost of cell signaling systems 44
5.2.2.2 Ethical issues related to embryonic stem cell signaling research 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging markets 45
5.2.3.2 Emergence of microfluidics in cell biology research 45
5.2.4 CHALLENGES 46
5.2.4.1 Complexities related to antibody and reagent development 46

6 GLOBAL CELL SIGNALING MARKET, BY SIGNALING TYPE 47
6.1 INTRODUCTION 48
6.2 ENDOCRINE SIGNALING 49
6.3 PARACRINE SIGNALING 50
6.4 AUTOCRINE SIGNALING 51
6.5 JUXTACRINE SIGNALING 52
6.6 OTHER SIGNALING TYPES 53

7 GLOBAL CELL SIGNALING MARKET, BY PRODUCT 54
7.1 INTRODUCTION 55
7.2 CONSUMABLES 56
7.2.1 ANTIBODIES 57
7.2.2 REAGENTS 58
7.2.3 ASSAY KITS 59
7.2.4 OTHER CONSUMABLES 60
7.3 INSTRUMENTS 60

8 GLOBAL CELL SIGNALING MARKET, BY TECHNOLOGY 63
8.1 INTRODUCTION 64
8.2 MICROSCOPY 65
8.3 FLOW CYTOMETRY 66
8.4 MASS SPECTROMETRY 66
8.5 WESTERN BLOTTING 67
8.6 ELISA 68
8.7 IMMUNOHISTOCHEMISTRY 69
8.8 OTHER TECHNOLOGIES 70

9 GLOBAL CELL SIGNALING MARKET, BY PATHWAY 71
9.1 INTRODUCTION 72
9.2 AKT SIGNALING PATHWAY 73
9.3 AMPK SIGNALING PATHWAY 73
9.4 ERBB/HER SIGNALING PATHWAY 74
9.5 HEDGEHOG SIGNALING PATHWAY 75
9.6 JAK/STAT SIGNALING PATHWAY 76
9.7 NOTCH SIGNALING PATHWAY 76
9.8 NF-ΚB SIGNALING PATHWAY 77
9.9 OTHER SIGNALING PATHWAYS 78

10 CELL SIGNALING MARKET, BY APPLICATION 79
10.1 INTRODUCTION 80
10.2 RESEARCH APPLICATIONS 81
10.2.1 CANCER RESEARCH 82
10.2.2 IMMUNOLOGY RESEARCH 83
10.2.3 STEM CELLS RESEARCH 84
10.2.4 OTHER RESEARCH APPLICATIONS 85
10.3 MEDICAL APPLICATIONS 86

11 GLOBAL CELL SIGNALING MARKET, BY REGION 87
11.1 INTRODUCTION 88
11.2 NORTH AMERICA 89
11.2.1 U.S. 94
11.2.2 CANADA 99
11.3 EUROPE 103
11.3.1 GERMANY 108
11.3.2 FRANCE 112
11.3.3 U.K. 117
11.3.4 ITALY 121
11.3.5 SPAIN 124
11.3.6 REST OF EUROPE (ROE) 128
11.4 ASIA 132
11.4.1 CHINA 137
11.4.2 JAPAN 141
11.4.3 INDIA 146
11.4.4 REST OF ASIA (ROA) 149
11.5 REST OF THE WORLD (ROW) 152

12 COMPETITIVE LANDSCAPE 157
12.1 INTRODUCTION 157
12.2 VENDOR DIVE OVERVIEW 157
12.2.1 VANGUARDS 157
12.2.2 INNOVATORS 157
12.2.3 DYNAMIC PLAYERS 157
12.2.4 EMERGING PLAYERS 157

12.3 COMPETITIVE BENCHMARKING 159
12.3.1 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS) 159
12.3.2 BUSINESS STRATEGY (FOR ALL 25 PLAYERS) 160
*Top 25 companies analyzed for this study are – Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.), BPS Bioscience, Inc. (U.S.), StressMarq Biosciences Inc. (U.S.), Abeomics, Inc. (U.S.), Sino Biological, Inc. (U.S.), RayBiotech, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), and Santa Cruz Biotechnology, Inc. (U.S.)

13 COMPANY PROFILES 161
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
13.1 MERCK KGAA 161
13.2 THERMO FISHER SCIENTIFIC INC. 167
13.3 BECTON, DICKINSON AND COMPANY 172
13.4 BECKMAN COULTER INC. (A SUBSIDIARY OF DANAHER CORPORATION) 175
13.5 BIO-RAD LABORATORIES, INC. 179
13.6 PERKINELMER, INC 185
13.7 QIAGEN N.V. 188
13.8 CELL SIGNALING TECHNOLOGY, INC. 191
13.9 PROMEGA CORPORATION 195
13.10 BIO-TECHNE CORPORATION 198
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14 KEY INNOVATORS 201
14.1 CISBIO BIOASSAYS 201
14.1.1 INNOVATIONS 201
14.2 MILTENYI BIOTEC 201
14.2.1 INNOVATIONS 201
14.3 CELL BIOLABS, INC. 202
14.3.1 INNOVATIONS 202

15 APPENDIX 203
15.1 INDUSTRY INSIGHTS 203
15.2 DISCUSSION GUIDE 204
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
15.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 210
15.5 AVAILABLE CUSTOMIZATIONS 211
15.6 RELATED REPORTS 211
15.7 AUTHOR DETAILS 212

LIST OF TABLES

TABLE 1 CELL SIGNALING: MARKET SNAPSHOT 31
TABLE 2 PROJECTED INCREASE IN CANCER PATIENTS, BY TYPE (2012, 2015, AND 2035) 42
TABLE 3 CELL SIGNALING MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION) 48
TABLE 4 ENDOCRINE SIGNALING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 5 PARACRINE SIGNALING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 6 AUTOCRINE SIGNALING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 7 JUXTACRINE SIGNALING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 8 OTHER CELL SIGNALING TYPES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 9 CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 55
TABLE 10 CELL SIGNALING CONSUMABLES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 56
TABLE 11 CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 57
TABLE 12 CELL SIGNALING ANTIBODIES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 13 CELL SIGNALING REAGENTS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 14 CELL SIGNALING ASSAY KITS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 15 OTHER CELL SIGNALING CONSUMABLES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 60
TABLE 16 CELL SIGNALING INSTRUMENTS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 17 CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION) 64
TABLE 18 CELL SIGNALING MARKET SIZE FOR MICROSCOPY, BY REGION,
2015–2022 (USD MILLION) 65
TABLE 19 CELL SIGNALING MARKET SIZE FOR FLOW CYTOMETRY, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 20 CELL SIGNALING MARKET SIZE FOR MASS SPECTROMETRY, BY REGION,
2015–2022 (USD MILLION) 67
TABLE 21 CELL SIGNALING MARKET SIZE FOR WESTERN BLOTTING, BY REGION,
2015–2022 (USD MILLION) 68
TABLE 22 CELL SIGNALING MARKET SIZE FOR ELISA, BY REGION,
2015–2022 (USD MILLION) 69
TABLE 23 CELL SIGNALING MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 24 CELL SIGNALING MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION,
2015–2022 (USD MILLION) 70
TABLE 25 CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION) 72
TABLE 26 AKT SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 27 AMPK SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 74
TABLE 28 ERBB/HER SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 75
TABLE 29 HEDGEHOG SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 75
TABLE 30 JAK/STAT SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 76
TABLE 31 NOTCH SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 77
TABLE 32 NF-ΚB SIGNALING PATHWAY MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 77
TABLE 33 OTHER SIGNALING PATHWAYS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 78
TABLE 34 CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION) 80
TABLE 35 CELL SIGNALING MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 81
TABLE 36 CELL SIGNALING MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE,
2015–2022 (USD MILLION) 82
TABLE 37 CELL SIGNALING MARKET SIZE FOR CANCER RESEARCH, BY REGION,
2015–2022 (USD MILLION) 83
TABLE 38 CELL SIGNALING MARKET SIZE FOR IMMUNOLOGY RESEARCH, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 39 CELL SIGNALING MARKET SIZE FOR STEM CELLS RESEARCH, BY REGION,
2015–2022 (USD MILLION) 85
TABLE 40 CELL SIGNALING MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 86
TABLE 41 CELL SIGNALING MARKET SIZE FOR MEDICAL APPLICATIONS, BY REGION,
2015–2022 (USD MILLION) 86
TABLE 42 CELL SIGNALING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 89
TABLE 43 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 91
TABLE 44 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 91
TABLE 45 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY PATHWAY,
2015–2022 (USD MILLION) 92
TABLE 46 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 92
TABLE 47 NORTH AMERICA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 93
TABLE 48 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 93
TABLE 49 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 94
TABLE 50 NORTH AMERICA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE,
BY TYPE, 2015–2022 (USD MILLION) 94
TABLE 51 U.S.: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 96
TABLE 52 U.S.: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 97
TABLE 53 U.S.: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 97
TABLE 54 U.S.: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 97
TABLE 55 U.S.: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 98
TABLE 56 U.S.: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION) 98
TABLE 57 U.S.: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 58 CANADA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 100
TABLE 59 CANADA: CELL SIGNALING MARKET SIZE, BY PATHWAY,
2015–2022 (USD MILLION) 100
TABLE 60 CANADA: CELL SIGNALING MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 101
TABLE 61 CANADA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 101
TABLE 62 CANADA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 101
TABLE 63 CANADA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 102
TABLE 64 CANADA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 102
TABLE 65 EUROPE: CELL SIGNALING MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 105
TABLE 66 EUROPE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 105
TABLE 67 EUROPE: CELL SIGNALING MARKET SIZE, BY PATHWAY,
2015–2022 (USD MILLION) 106
TABLE 68 EUROPE: CELL SIGNALING MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 106
TABLE 69 EUROPE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 106
TABLE 70 EUROPE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 107
TABLE 71 NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 107
TABLE 72 EUROPE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 108
TABLE 73 GERMANY: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 109
TABLE 74 GERMANY: CELL SIGNALING MARKET SIZE, BY PATHWAY,
2015–2022 (USD MILLION) 110
TABLE 75 GERMANY: CELL SIGNALING MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 111
TABLE 76 GERMANY: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 111
TABLE 77 GERMANY: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 111
TABLE 78 GERMANY: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 112
TABLE 79 GERMANY: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 112
TABLE 80 FRANCE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 114
TABLE 81 FRANCE: CELL SIGNALING MARKET SIZE, BY PATHWAY,
2015–2022 (USD MILLION) 114
TABLE 82 FRANCE: CELL SIGNALING MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 115
TABLE 83 FRANCE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 115
TABLE 84 FRANCE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 115
TABLE 85 FRANCE: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 116
TABLE 86 FRANCE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 116
TABLE 87 U.K.: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 118
TABLE 88 U.K.: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 118
TABLE 89 U.K.: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 118
TABLE 90 U.K.: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 119
TABLE 91 U.K.: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 119
TABLE 92 U.K.: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION) 120
TABLE 93 U.K.: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 120
TABLE 94 ITALY: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 122
TABLE 95 ITALY: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 122
TABLE 96 ITALY: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 123
TABLE 97 ITALY: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 123
TABLE 98 ITALY: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 123
TABLE 99 ITALY: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 124
TABLE 100 ITALY: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 124
TABLE 101 SPAIN: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 125
TABLE 102 SPAIN: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 126
TABLE 103 SPAIN: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 126
TABLE 104 SPAIN: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 126
TABLE 105 SPAIN: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 127
TABLE 106 SPAIN: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 127
TABLE 107 SPAIN: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 128
TABLE 108 ROE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 129
TABLE 109 ROE: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 129
TABLE 110 ROE: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 129
TABLE 111 ROE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 130
TABLE 112 ROE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 130
TABLE 113 ROE: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION) 131
TABLE 114 ROE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 131
TABLE 115 ASIA: CELL SIGNALING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 134
TABLE 116 ASIA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 134
TABLE 117 ASIA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 135
TABLE 118 ASIA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 135
TABLE 119 ASIA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 135
TABLE 120 ASIA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 136
TABLE 121 ASIA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 136
TABLE 122 ASIA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 137
TABLE 123 CHINA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 138
TABLE 124 CHINA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 139
TABLE 125 CHINA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 139
TABLE 126 CHINA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 139
TABLE 127 CHINA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 140
TABLE 128 CHINA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 140
TABLE 129 CHINA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 141
TABLE 130 JAPAN: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 142
TABLE 131 JAPAN: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 143
TABLE 132 JAPAN: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 144
TABLE 133 JAPAN: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 144
TABLE 134 JAPAN: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 144
TABLE 135 JAPAN: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 145
TABLE 136 JAPAN: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 145
TABLE 137 INDIA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 147
TABLE 138 INDIA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 147
TABLE 139 INDIA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 147
TABLE 140 INDIA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 148
TABLE 141 INDIA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 148
TABLE 142 INDIA: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 149
TABLE 143 INDIA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 149
TABLE 144 ROA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 150
TABLE 145 ROA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 150
TABLE 146 ROA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 150
TABLE 147 ROA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 151
TABLE 148 ROA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015–2022 (USD MILLION) 151
TABLE 149 ROA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION) 152
TABLE 150 ROA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 152
TABLE 151 ROW: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE,
2015–2022 (USD MILLION) 154
TABLE 152 ROW: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015–2022 (USD MILLION) 154
TABLE 153 ROW: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION) 154
TABLE 154 ROW: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 155
TABLE 155 ROW: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY,
2015–2022 (USD MILLION) 155
TABLE 156 ROW: CELL SIGNALING MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 156
TABLE 157 ROW: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 156


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 23
FIGURE 2 CELL SIGNALING MARKET: BOTTOM-UP APPROACH 27
FIGURE 3 TOP-DOWN APPROACH 28
FIGURE 4 DATA TRIANGULATION METHODOLOGY 29
FIGURE 5 CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2017 VS. 2022 (USD BILLION) 32
FIGURE 6 CELL SIGNALING MARKET SIZE, BY PATHWAY, 2017 VS. 2022 (USD BILLION) 33
FIGURE 7 CELL SIGNALING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD BILLION) 33
FIGURE 8 CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION) 34
FIGURE 9 CELL SIGNALING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD BILLION) 34
FIGURE 10 CELL SIGNALING MARKET SIZE, BY REGION, 2017 VS. 2022 (USD BILLION) 35
FIGURE 11 GROWING PREVALENCE OF CHRONIC DISEASES AND AVAILABILITY OF FUNDING FOR CELL-BASED RESEARCH ARE DRIVING THE GROWTH OF THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD 36
FIGURE 12 NORTH AMERICA & ENDOCRINE SEGMENTS ARE ESTIMATED TO COMMAND THE LARGEST MARKET SHARE IN 2017 37
FIGURE 13 AKT SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 38
FIGURE 14 ASIA TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022 38
FIGURE 15 CELL SIGNALING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 40
FIGURE 16 DIABETES CASES, 2015 VS. 2040 (MILLION) 41
FIGURE 17 ENDOCRINE SIGNALING SEGMENT TO DOMINATE THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD 48
FIGURE 18 NORTH AMERICA TO DOMINATE THE ENDOCRINE SIGNALING MARKET DURING THE FORECAST PERIOD 49
FIGURE 19 NORTH AMERICA TO DOMINATE THE AUTOCRINE SIGNALING MARKET DURING THE FORECAST PERIOD 52
FIGURE 20 CONSUMABLES TO DOMINATE THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD 55
FIGURE 21 ANTIBODIES TO DOMINATE THE CELL SIGNALING CONSUMABLES MARKET IN 2017–2022 56
FIGURE 22 NORTH AMERICA TO DOMINATE THE CELL SIGNALING INSTRUMENTS MARKET DURING 2017–2022 61
FIGURE 23 MICROSCOPY SEGMENT TO DOMINATE THE CELL SIGNALING TECHNOLOGY MARKET DURING THE FORECAST PERIOD 64
FIGURE 24 AKT PATHWAY SEGMENT TO DOMINATE THE CELL SIGNALING MARKET IN
2017–2022 72
FIGURE 25 RESEARCH APPLICATIONS SEGMENT WILL CONTINUE TO DOMINATE THE CELL SIGNALING MARKET IN 2022 80
FIGURE 26 ASIAN CELL SIGNALING MARKET TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 88
FIGURE 27 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035 89
FIGURE 28 NORTH AMERICA: MARKET SNAPSHOT 90
FIGURE 29 U.S.: CANCER INCIDENCE & MORTALITY, 2012–2035 95
FIGURE 30 ENDOCRINE SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. CELL SIGNALING MARKET IN 2017 96
FIGURE 31 CANADA: CANCER INCIDENCE & MORTALITY, 2012–2035 99
FIGURE 32 EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035 103
FIGURE 33 EUROPE: MARKET SNAPSHOT 104
FIGURE 34 GERMANY: CANCER INCIDENCE & MORTALITY, 2012–2035 108
FIGURE 35 GERMANY: REVENUE & R&D EXPENDITURES OF MAJOR BIOTECHNOLOGY COMPANIES, 2012–2015 (USD BILLION) 109
FIGURE 36 AKT SEGMENT TO REGISTER THE HIGHEST CAGR IN THE GERMAN CELL SIGNALING MARKET DURING THE FORECAST PERIOD 110
FIGURE 37 FRANCE: CANCER INCIDENCE & MORTALITY, 2012–2035 113
FIGURE 38 U.K.: CANCER INCIDENCE & MORTALITY, 2012–2035 117
FIGURE 39 ITALY: CANCER INCIDENCE & MORTALITY, 2012–2035 121
FIGURE 40 SPAIN: CANCER INCIDENCE & MORTALITY, 2012–2035 125
FIGURE 41 ASIA: CANCER INCIDENCE & MORTALITY, 2012–2035 132
FIGURE 42 ASIA: MARKET SNAPSHOT 133
FIGURE 43 CHINA: CANCER INCIDENCE & MORTALITY, 2012–2035 138
FIGURE 44 JAPAN: CANCER INCIDENCE & MORTALITY, 2012–2035 141
FIGURE 45 CONSUMABLES SEGMENT TO REGISTER THE HIGHEST CAGR IN THE JAPANESE CELL SIGNALING MARKET DURING THE FORECAST PERIOD 143
FIGURE 46 INDIA: CANCER INCIDENCE & MORTALITY, 2012–2035 146
FIGURE 47 ROW: MARKET SNAPSHOT 153
FIGURE 48 DIVE CHART: CELL SIGNALING MARKET 158
FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2016) 161
FIGURE 50 MERCK KGAA: PRODUCT OFFERING SCORECARD 165
FIGURE 51 MERCK KGAA: BUSINESS STRATEGY SCORECARD 165
FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016) 167
FIGURE 53 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERING SCORECARD 169
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: BUSINESS STRATEGY SCORECARD 170
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016) 172
FIGURE 56 BECTON, DICKINSON AND COMPANY: PRODUCT OFFERING SCORECARD 173
FIGURE 57 BECTON, DICKINSON AND COMPANY: BUSINESS STRATEGY SCORECARD 174
FIGURE 58 DANAHER CORPORATION: COMPANY SNAPSHOT (2016) 175
FIGURE 59 DANAHER CORPORATION: PRODUCT OFFERING SCORECARD 177
FIGURE 60 DANAHER CORPORATION: BUSINESS STRATEGY SCORECARD 178
FIGURE 61 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016) 179
FIGURE 62 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERING SCORECARD 183
FIGURE 63 BIO-RAD LABORATORIES, INC.:: BUSINESS STRATEGY SCORECARD 184
FIGURE 64 PERKINELMER, INC.: COMPANY SNAPSHOT (2016) 185
FIGURE 65 PERKINELMER, INC.: PRODUCT OFFERING SCORECARD 186
FIGURE 66 PERKINELMER, INC.: BUSINESS STRATEGY SCORECARD 187
FIGURE 67 QIAGEN N.V.: COMPANY SNAPSHOT (2016) 188
FIGURE 68 QIAGEN N.V.: PRODUCT OFFERING SCORECARD 189
FIGURE 69 QIAGEN N.V.: BUSINESS STRATEGY SCORECARD 190
FIGURE 70 CELL SIGNALING TECHNOLOGY INC.: PRODUCT OFFERING SCORECARD 193
FIGURE 71 CELL SIGNALING TECHNOLOGY INC.: BUSINESS STRATEGY SCORECARD 193
FIGURE 72 PROMEGA CORPORATION: PRODUCT OFFERING SCORECARD 196
FIGURE 73 PROMEGA CORPORATION: BUSINESS STRATEGY SCORECARD 196
FIGURE 74 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2016) 198
FIGURE 75 BIO-TECHNE CORPORATION: PRODUCT OFFERING SCORECARD 199
FIGURE 76 BIO-TECHNE CORPORATION: BUSINESS STRATEGY SCORECARD 200


【レポートのキーワード】

細胞内シグナル伝達、シグナル伝達系、内分泌、傍分泌、パラクリンシグナリング

★調査レポート[細胞内シグナル伝達の世界市場予測(~2022年):内分泌、傍分泌] (コード:MAM-BT5257)販売に関する免責事項を必ずご確認ください。
★調査レポート[細胞内シグナル伝達の世界市場予測(~2022年):内分泌、傍分泌]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆